Clinical Trial Update: Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 comparative effectiveness study of intravitreal aflibercept, bevacizumab, and ranibizumab for diabetic macular edema has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• Bevacizumab (bevacizumab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2015-12-16